<i>Ex vivo</i> C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy.
<i>Ex vivo</i> C5b-9 沉積測試以監測臨床及亞臨床型非典型溶血性尿毒症綜合症及移植相關血栓性微血管病中的補體活性。
Kidney Int Rep 2024-07-31
Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
溶血與血管內皮糖ocalyx的硫酸肝素變化以及血栓性微血管病中的局部補體活化有關。
Kidney Int 2023-07-27
Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome.
嗎Complement Factor I 基因變異在一個由過高嗜酸性白血球症候群引發的非典型溶血性尿毒症候群。
Nephron 2024-02-08
De novo atypical hemolytic uremic syndrome associated with C3 gene mutation after kidney transplantation: a rare case of life-threatening diffuse alveolar hemorrhage in an adolescent.
腎移植後與C3基因突變相關的新發特異性溶血性尿毒症候群:一名青少年罹患危及生命的罕見弥漫性肺泡出血症例。
Nephron 2023-11-26
Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition.
非典型溶血性尿毒症個案結果:觸發因素及補體異常在對C5抑制反應中的角色。
J Nephrol 2024-01-27
Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study.
異常溶血性尿毒症候群腎移植患者體外補體失調測試:一項初步研究。
Kidney Int Rep 2024-02-06
Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition.
產後出血相關的血栓性微血管病變特徵及短期補體抑制的作用。
Kidney Int Rep 2024-05-20